Journal
/
Cancer Research
/
Glioblastom-Rezidiv-Post-Resektionsmodell für therapeutische Hydrogel-Untersuchungen
JoVE Journal
Cancer Research
This content is Free Access.
JoVE Journal Cancer Research
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Please note that all translations are automatically generated. Click here for the English version.

Glioblastom-Rezidiv-Post-Resektionsmodell für therapeutische Hydrogel-Untersuchungen

Deutsch

Automatically Generated

966 Views

•

04:46 min

•

February 24, 2023

DOI:

10.3791/65026-v

DOI:
10.3791/65026-v

•

04:46 min
February 24, 2023

•

16 Views
, , , , , ,
1Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School,Nanjing Medical University, 2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing Medical University

Summary

Automatically generated

Das vorliegende Protokoll etabliert ein Glioblastom (GBM) Rezidivmodell nach Resektion unter Verwendung von Mikroskopie, um die therapeutische Wirkung eines injizierbaren, bioresponsiven Hydrogels in vivo zu untersuchen.

Explore More Videos

GlioblastomaRelapsePost-resectionModelTherapeutic HydrogelTumor RecurrenceGBM Recurrence ModelLocal TreatmentAnimal PreparationStereotactic ApparatusTumor Cell SuspensionMicrosyringeBioluminescent ImagingOrthotopic Intracranial GBM Model

Read Article

Cite this Article

Sun, S., Shi, D., Liu, J., Lu, J., Dou, P., Zhou, Z., Chen, Y. Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations. J. Vis. Exp. (192), e65026, doi:10.3791/65026 (2023).

Download .ris file

Copy

Share Video

.

Copy